Regulatory Story
Go to market news section View chart   Print
RNS
Derriston Capital PLC  -  DERR   

Director Declaration

Released 12:18 27-Mar-2017

RNS Number : 6302A
Derriston Capital PLC
27 March 2017
 

Derriston Capital plc

 

Director Declaration

 

Derriston Capital plc, which has been created to consider opportunities within the global medical technology industry, announces that Harry Hyman, non-executive Chairman, is a non-executive Director of BioPharma Credit plc, which began trading on the London Stock Exchange this morning.

 

For information please contact:

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

lifesciences@walbrookpr.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDNMMGZFMNVGNZM
Close


London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.

 


Director Declaration - RNS